Publications

Yangyang Li, Weiyu Chen, Yuchen Qi, Shuai Wang, Lei Li,* Wanlin Li, Tingting Xie, Huanle Zhu, Zhe Tang,* and Min Zhou*. H 2 S-Scavenged and Activated Iron Oxide-Hydroxide Nanospindles for MRI-Guided Photothermal Therapy and Ferroptosis in Colon Cancer. Small. 2020 Aug 12;e2001356. doi: 10.1002/smll.202001356.

Kezhong Tang1, Bo Zhang1, Linping Dong1,Lantian Wang1 and Zhe Tang. Radiofrequency ablation versus traditional liver resection and chemotherapy for liver metastases from gastric cancer. Journal of International Medical Research. 2020 Jul;48(7):300060520940509. doi: 10.1177/0300060520940509

Tang K, Zhang B, Dong L, Wang L, Jin Y, Tang Z. Successful treatment of a huge hepatic carcinoma with right portal vein thrombosis. Medicine (Baltimore). 2020 Apr;99(17):e19636.

Tang Z.CSCO ablation expert workshop report:Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic. J Cancer Res Ther. 2020;16(2):350-355.

Tang K, Liu Y, Dong L, Zhang B, Wang L, Chen J, Chen G, Tang Z. Influence of thermal ablation of hepatic metastases from gastric adenocarcinoma on long-term survival: Systematic review and pooled analysis.Medicine (Baltimore). 2018 dec;97(49):e13525. 

Tang Z, Kang M, Zhang B, Chen J, Fang H, Ye Q, Jiang B, Wu Y. Advantage of sorafenib combined with radiofrequency ablation for treatment of hepatocellular carcinoma. Tumori. 2017 May 12;103(3):286-291. doi: 10.5301/tj.5000585. 

Tang Z, Zhu Y, Tang K, Dong L, Yang B, Fang H, Wu Y, Zhang B. Laparoscopic combined with percutaneous ablation for hepatocellular carcinoma under liver capsule: A single Chinese center experience of thirty patients.  J Cancer Res Ther. 2016 Dec;12(Supplement):C143-C147. 

Tang Z, Ni L, Javidiparsijani S, Hu F, A Gatto L, Cooney R, Wang G*. Enhanced Liver Autophagic Activity Improves Survival of Septic Mice Lacking Surfactant Proteins A and D. Tohoku J Exp Med. 2013;231(2):127-138.

Tang Z, Fang H, Kang M, Zhang B, Dong X, Chen X, Xu J, Chen J, Wu Y. Percutaneous radiofrequency ablation for liver tumors: Is it safer and more effective in low-risk areas than in high-risk areas?  Hepatol Res. 2011 Jul;41(7):635-40.